Subscribe To Our Newsletter
Abonnez-vous à notre bulletin
Round 10 Results, by Country
GFO Issue 135

Round 10 Results, by Country

Author:

Bernard Rivers

Article Type:
News

Article Number: 3

ABSTRACT Details are provided of the Board's decision regarding each eligible Round 10 proposal.

Based on advice from the TRP, the Board divided eligible Round 10 proposals into five categories, as follows:

  • Category 1: Approved proposals requiring no or minor clarifications; any clarifications need to be provided within eight weeks and then given a final approval by the TRP Chair or Vice-Chair.
  • Category 2: Proposals that are approved subject to the required clarifications being provided within a limited timeframe (six weeks for the applicant to provide an initial detailed response to the TRP queries, and a further three months to obtain the final TRP approval should further clarifications be requested). The TRP Chair and Vice-Chair need to give final approval.
  • Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
  • Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in a future round following major revision.
  • Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.

The Board approved all proposals in Categories 1, 2 and 2B.

Table 8 provides a summary of the Round 10 results by category. Tables 9 and 10 show the results for each applicant.

Table 8: Round 10 results by category

 

 

Category

Number of proposals

TRP-recommended funding

(Years 1-2)

(Years 1-5)

Approved: Category 1

3

$0.05 b.

$0.14 b.

Approved: Category 2

49

$1.03 b.

$2.73 b.

Approved: Category 2B

27

$0.65 b.

$1.85 b.

Subtotal: All Approved Proposals:

79

$1.73 b.

$4.72 b.

Not Approved: Category 3

56

$1.64 b.

$4.21 b.

Not Approved: Category 4

15

$0.78 b.

$2.22 b.

Not Approved: Parts of Category 1, 2 and 2B proposals not recommended for funding *

n/a

$0.14 b.

$0.48 b.

Subtotal: All Non-Approved Proposals:

71

$2.56 b.

$6.91 b.

Total: All Proposals

150

$4.30 b.

$11.63 b.

* This refers to a situation where a disease proposal with an HSS request attached has been submitted, and the TRP has recommended, and the Board has approved, either the disease proposal or the HSS request, but not both.

Table 9: Round 10 results, by country

Notes:

1. In the following table, DP = disease part.

2. For approved proposals, the costs shown in the last two columns are the amounts recommended by the TRP. For proposals that were not approved, the costs are the amounts requested by the applicant.

 

Applicant

Disease component

Applicant type

Decision

Cate-gory

Cost

(Years 1-2)

(Years 1-5)

Afghanistan TB (DP + HSS part)

CCM

Approved

2

€ 16,132,533

€ 23,330,719

Angola HIV

CCM

Approved

2B

$25,877,952

$68,884,971

Angola Malaria

CCM

Approved

1

$40,435,549

$111,239,055

Argentina HIV MARPs

CCM

Approved

2

$4,933,812

$12,500,000

Armenia HIV MARPs

CCM

Not approved

3

€ 2,328,230

€ 4,817,816

Armenia * TB (DP)

CCM

Approved

2

€ 3,310,881

€ 8,881,651

Armenia TB (HSS part)

CCM

Not approved

n/a

€ 1,180,614

€ 2,159,904

Azerbaijan HIV MARPs

CCM

Not approved

3

$3,546,724

$12,466,986

Azerbaijan Malaria

CCM

Not approved

3

€ 1,880,538

€ 3,571,100

Bangladesh ** TB

CCM

Approved

2B

$11,677,496

$98,543,757

Belize HIV MARPs

CCM

Not approved

3

$2,602,746

$6,722,026

Belize TB

CCM

Not approved

4

$2,823,065

$5,960,681

Benin HIV

CCM

Not approved

3

€ 11,286,254

€ 21,692,352

Benin TB

CCM

Not approved

3

€ 993,858

€ 2,274,009

Bosnia & Herz. HIV

CCM

Not approved

4

€ 2,800,310

€ 5,497,810

Botswana HIV

CCM

Not approved

3

$47,926,893

$137,642,491

Botswana TB

CCM

Not approved

3

$10,828,604

$25,258,210

Brazil HIV MARPs

CCM

Not approved

3

$5,000,000

$12,500,000

Burkina Faso HIV (DP)

CCM

Approved

2B

€ 38,993,903

€ 97,448,392

Burkina Faso HIV (HSS part)

CCM

Not approved

n/a

€ 10,272,650

€ 24,384,963

Burundi TB

CCM

Not approved

3

$4,830,351

$13,212,893

Cambodia HIV

CCM

Not approved

3

$23,124,597

$47,452,279

Cambodia TB (DP + HSS part)

CCM

Not approved

3

$47,313,760

$132,570,309

Cameroon HIV

CCM

Approved

2B

€ 30,200,540

€ 97,411,942

Cape Verde Malaria

CCM

Approved

2B

€ 968,724

€ 1,414,366

Central Af. Rep. HIV (DP + HSS part)

CCM

Not approved

3

€ 29,077,778

€ 64,570,395

Chad HIV

CCM

Not approved

3

€ 31,801,787

€ 94,985,597

Chad TB (DP + HSS part)

CCM

Not approved

3

€ 11,599,749

€ 22,450,241

China Malaria

CCM

Approved

2B

$5,830,102

$15,704,363

Colombia TB

CCM

Approved

2B

$5,390,584

$11,271,656

Congo Rep. HIV

CCM

Not approved

3

€ 4,674,974

€ 9,978,943

Congo DR HIV

CCM

Not approved

3

$111,533,674

$295,297,357

Congo DR Malaria

CCM

Approved

2

$73,922,870

$185,122,386

Cote d’Ivoire HIV (DP + HSS part)

CCM

Not approved

3

€ 57,632,004

€ 133,432,755

Djibouti TB

CCM

Approved

2

€ 2,461,552

€ 6,080,117

Dominican Rep. HIV MARPs

CCM

Not approved

4

$4,950,940

$12,496,996

Eritrea * HIV (DP + HSS part)

CCM

Approved

2

$20,818,140

$59,897,311

Eritrea * ** TB

CCM

Approved

2B

$7,316,801

$22,815,431

Ethiopia HIV

CCM

Not approved

3

$88,149,150

$176,458,326

Ethiopia Malaria (DP + HSS part)

CCM

Not approved

3

$97,848,890

$245,989,480

Ethiopia TB

CCM

Not approved

3

$21,107,334

$82,169,387

Georgia HIV MARPs

CCM

Approved

2

€ 3,105,210

€ 8,860,077

Georgia TB

CCM

Approved

2

€ 7,695,603

€ 21,727,729

Ghana HIV (DP + HSS part)

CCM

Not approved

4

$499,428,723

$1,420,138,447

Ghana * TB

CCM

Approved

2B

$31,897,744

$77,418,445

Guinea HIV (DP + HSS part)

CCM

Approved

2B

$20,877,516

$56,875,437

Guinea Malaria

CCM

Approved

2B

$32,046,938

$46,625,648

Guinea Bissau HIV (DP + HSS part)

CCM

Not approved

3

€ 26,167,631

€ 63,815,647

Guyana TB

CCM

Not approved

4

$486,607

$1,050,801

Honduras TB

CCM

Approved

2B

$6,030,951

$12,402,425

India HIV

CCM

Not approved

3

$21,412,956

$61,404,090

Indonesia TB (DP + HSS part)

CCM

Approved

2

$47,727,271

$157,544,680

Iran Malaria

CCM

Approved

2

$9,363,548

$19,578,464

Jordan TB

CCM

Approved

2

$2,078,829

$4,666,284

Kazakhstan HIV MARPs

CCM

Approved

2

$2,404,755

$12,449,062

Kenya HIV

CCM

Approved

2B

$93,376,285

$345,103,871

Kenya Malaria

CCM

Approved

2

$49,979,579

$138,370,324

Kyrgyz Rep. HIV

CCM

Approved

2

$11,207,840

$41,480,486

Kyrgyz Rep. TB

CCM

Not approved

3

$3,842,777

$5,659,777

Lao PDR TB (HSS part)

CCM

Not approved

n/a

$8,155,754

$17,158,018

Lao PDR ** TB (DP)

CCM

Approved

2

$3,255,999

$12,887,910

Lesotho HIV

CCM

Not approved

3

$29,594,699

$65,273,286

Liberia Malaria (DP + HSS part)

CCM

Approved

2

$28,698,063

$68,892,692

Liberia TB

CCM

Approved

2B

$2,862,226

$16,061,899

Macedonia HIV MARPs

CCM

Approved

1

€ 2,825,259

€ 9,407,934

Macedonia TB

CCM

Approved

2

€ 2,901,528

€ 6,112,713

Madagascar HIV (DP + HSS part)

CCM

Not approved

3

$46,050,649

$110,739,971

Malawi HIV

CCM

Not approved

3

$164,254,176

$561,450,164

Malaysia HIV MARPs

CCM

Approved

2B

$4,672,630

$12,405,288

Maldives HIV MARPs

CCM

Not approved

3

$2,880,814

$8,044,746

Mali Malaria

CCM

Approved

2B

€ 24,827,735

€ 94,873,243

Mali TB

CCM

Approved

2

€ 8,053,957

€ 13,773,341

Mauritius HIV MARPs

CCM

Not approved

3

$2,870,148

$12,435,364

Moldova HIV MARPs

CCM

Not approved

3

$3,849,298

$12,491,713

Mongolia HIV

CCM

Not approved

4

$2,218,185

$7,248,739

Mongolia ** TB (DP + HSS part)

CCM

Approved

2

$3,696,354

$9,052,049

Morocco HIV

CCM

Approved

2

$14,672,516

$43,597,649

Morocco TB

CCM

Approved

2

$5,014,439

$10,795,334

Mozambique HIV

CCM

Not approved

3

$54,163,105

$131,214,912

Mozambique TB

CCM

Not approved

3

$25,407,092

$69,822,783

Namibia HIV

CCM

Not approved

4

$15,248,614

$44,292,453

Namibia TB

CCM

Approved

2

$12,524,672

$32,994,241

Nepal HIV

CCM

Approved

2

$16,150,553

$57,273,249

Nicaragua TB

CCM

Not approved

3

$4,106,578

$8,247,665

Niger HIV

CCM

Not approved

3

€ 30,335,989

€ 73,945,907

Niger Malaria

CCM

Not approved

3

€ 72,627,052

€ 130,641,962

Niger TB (DP + HSS part)

CCM

Approved

2B

€ 19,035,383

€ 42,226,096

Nigeria HIV (DP + HSS part)

CCM

Not approved

4

$97,491,288

$383,708,645

Pakistan * Malaria (DP)

CCM

Approved

2B

$23,395,667

$51,516,709

Pakistan Malaria (HSS part)

CCM

Not approved

n/a

$15,199,740

$21,594,900

Panama HIV MARPs

CCM

Approved

2

$4,202,744

$10,273,513

Papua NG * HIV (DP + HSS part)

CCM

Approved

2

$23,419,727

$46,697,052

Peru HIV MARPs

CCM

Approved

2

$4,999,999

$12,499,997

Peru Malaria

CCM

Not approved

3

$2,835,863

$7,741,937

Peru TB

CCM

Not approved

3

$15,481,203

$29,837,075

Russian Fed. TB

CCM

Approved

2B

$63,472,958

$126,926,245

Russian Fed. TB Sub-CCM Not approved

4

€ 20,170,145

€ 36,360,264

Sao Tome & P. HIV

CCM

Approved

2

$1,279,852

$2,476,713

Senegal Malaria

CCM

Approved

2

€ 21,650,781

€ 62,865,723

Senegal * ** TB

CCM

Approved

2

€ 6,335,035

€ 17,460,725

Sierra Leone Malaria

CCM

Approved

2

$23,255,609

$62,649,856

Sierra Leone TB (DP + HSS part)

CCM

Not approved

3

$34,333,373

$77,234,629

Somalia Malaria (DP + HSS part) Non-CCM Approved

2

$39,333,002

$84,550,325

Somalia * ** TB Non-CCM Approved

2B

$14,213,393

$58,380,928

South Africa HIV

CCM

Approved

2

$128,481,275

$302,717,719

Sri Lanka TB (DP + HSS part)

CCM

Not approved

3

$11,845,852

$25,088,859

Sudan North HIV

CCM

Approved

2

$21,944,538

$61,919,606

Sudan North Malaria

CCM

Approved

2B

$61,256,082

$182,841,841

Sudan South HIV Sub-CCM Not approved

4

$65,528,320

$135,697,425

Sudan South Malaria Sub-CCM Approved

2

$26,486,653

$98,618,453

Sudan South TB Sub-CCM Not approved

3

$16,374,061

$50,114,047

Swaziland HIV

CCM

Not approved

3

$34,723,593

$89,609,304

Swaziland ** TB

CCM

Approved

2

$11,202,195

$39,004,228

Syria * HIV MARPs

CCM

Approved

2B

$1,723,169

$3,396,722

Tajikistan HIV

CCM

Not approved

3

$20,521,257

$64,745,498

Tajikistan TB

CCM

Not approved

3

$49,913,253

$115,418,678

Tanzania HIV

CCM

Not approved

3

$50,880,157

$113,178,230

Tanzania TB

CCM

Not approved

3

$33,201,781

$68,786,103

Thailand HIV

CCM

Approved

2

$15,398,249

$42,088,572

Thailand * Malaria

CCM

Approved

2B

$32,500,432

$78,378,690

Thailand TB

CCM

Approved

2

$12,344,773

$31,716,829

Timor-Leste HIV

CCM

Approved

1

$6,798,682

$14,254,688

Timor-Leste * Malaria

CCM

Approved

2B

$7,170,680

$22,349,915

Timor-Leste TB

CCM

Not approved

3

$2,706,769

$9,661,901

Togo HIV

CCM

Not approved

3

€ 6,280,885

€ 16,083,684

Tunisia HIV MARPs

CCM

Not approved

3

$4,144,950

$12,499,365

Uganda HIV (DP)

CCM

Not approved

n/a

$55,834,292

$217,300,859

Uganda HIV (HSS part)

CCM

Approved

2

$17,917,965

$25,251,193

Uganda Malaria

CCM

Approved

2

$53,167,057

$155,963,673

Uganda TB

CCM

Approved

2

$10,391,585

$24,757,129

Ukraine HIV

CCM

Approved

2

$95,842,099

$305,535,421

Uruguay HIV MARPs

CCM

Approved

2

$3,953,375

$9,572,417

Uzbekistan HIV

CCM

Approved

2

$9,519,645

$14,828,347

Vietnam HIV (DP)

CCM

Not approved

n/a

$45,071,739

$188,864,423

Vietnam HIV (HSS part)

CCM

Approved

2B

$42,102,165

$86,636,150

Yemen HIV (DP + HSS part)

CCM

Not approved

3

$14,565,766

$32,312,943

Zambia * HIV

CCM

Approved

2

$102,851,986

$259,216,608

Zanzibar (Tanz.) TB

CCM

Approved

2

$2,633,434

$5,912,925

Zimbabwe HIV (DP + HSS part)

CCM

Not approved

3

$118,402,303

$342,054,472

Zimbabwe Malaria

CCM

Approved

2

$14,550,666

$24,960,569

Zimbabwe TB

CCM

Not approved

3

$12,193,205

$25,507,117

Total – 135 country-based proposals

* The TRP-recommended funding has been reduced from the requested amount because the TRP removed certain elements from the proposal.

** These are consolidated proposals. The TRP-recommended funding has been reduced to remove amounts included in the proposals for existing, already funded programmes.

Table 10: Round 10 results for regional applicants

Note: For approved proposals, the costs shown in the last two columns are the amounts recommended by the TRP. For proposals that were not approved, the costs are the amounts requested by the applicant.

 

Applicant

Disease component

Applicant type

Decision

Cate-gory

Cost

Years 1-2

Years 1-5

AMREF (Re Burundi, Ethiopia, Kenya, Tanzania, Uganda) TB

RO

Not approved

4

$29,868,200

$63,996,437

APN+ (Re Bangladesh, Indonesia, Lao PDR, Nepal, Pakistan, Philippines, Viet Nam) * HIV

RO

Approved

2

$1,200,000

$3,000,000

ASICAL (Re Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay) HIV MARPs

RO

Not approved

3

$4,827,281

$11,149,346

CONGA (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama) HIV MARPs

RO

Not approved

4

$4,506,212

$12,451,594

ECSA (Re Zambia, Zimbabwe) TB

RO

Not approved

3

$3,322,054

$14,593,861

GLIA (Re Burundi, Congo DR, Kenya, Rwanda, Tanzania, Uganda) HIV MARPs

RO

Not approved

4

$4,873,647

$12,499,735

HIVOS-SA (Re Lesotho, Mauritius, Namibia, South Africa, Swaziland) HIV

RO

Not approved

4

$12,130,614

$36,066,771

ISEAN-HIVOS (Re Indonesia, Malaysia, Philippines, Timor-Leste) HIV MARPs

RO

Approved

2B

$4,767,802

$12,473,395

MENAHRA (Re Afghanistan, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Morocco, Oman, West Bank and Gaza, Pakistan, Syria, Tunisia) * HIV MARPs

RO

Approved

2B

$3,209,492

$8,352,698

Meso (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama) HIV

RCM

Not approved

3

$7,868,536

$23,214,775

MOZIZA (Re Mozambique, South Africa, Zimbabwe) Malaria

RCM

Not approved

4

$12,322,727

$28,043,158

OECS (Re Antigua and Barbuda, Dominica, Grenada, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and Grenadines) HIV

RCM

Not approved

3

$3,112,877

$9,059,745

REDCA+ (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama) ** HIV

RO

Approved

2

$2,366,057

$9,229,855

REDLACTRANS (Re Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay) HIV MARPs

RO

Not approved

3

$4,994,209

$12,500,000

REDTRASEX (Re Argentina, Bolivia, Brazil, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay) HIV MARPs

RO

Approved

2

$4,328,974

$12,496,279

Total – 15 regional proposals

 

RO = Regional organisation RCM = Regional coordinating mechanism

* The TRP-recommended funding has been reduced from the requested amount because the TRP removed certain elements from the proposal.

** This is a consolidated proposal. The TRP-recommended funding has been reduced to remove amounts included in the proposal for existing, already funded programmes.

Tags :

Leave a Reply

Your email address will not be published.

Aidspan

Categories*

Loading
Aidspan

Categories*

Loading